eGFR (CKD-EPI 2021)
Estimated glomerular filtration rate, race-free equation
- KDIGO 2024 GFR categories
- NKF-ASN Task Force 2021
Sources last checked: 2026-10-13
eGFR (CKD-EPI 2021)
Estimated glomerular filtration rate, race-free equation
Not valid in acute kidney injury, pregnancy, or extremes of muscle mass. For drug dosing, some sources still ask for Cockcroft-Gault.
Interpretation
| G5 — kidney failure | < 15 mL/min/1.73 m² (KDIGO G5). |
|---|---|
| G4 — severe reduction | 15–29 mL/min/1.73 m². |
| G3b — moderate–severe reduction | 30–44 mL/min/1.73 m². |
| G3a — mild–moderate reduction | 45–59 mL/min/1.73 m². |
| G2 — mild reduction | 60–89 mL/min/1.73 m². A CKD diagnosis needs an additional marker of kidney damage. |
| G1 — normal or high | ≥ 90 mL/min/1.73 m². |
What is the eGFR (CKD-EPI 2021)?
The CKD-EPI 2021 creatinine equation estimates glomerular filtration rate (eGFR) from serum creatinine, age and sex, without the race coefficient of the 2009 version. Inker and colleagues refitted it on pooled North American cohorts with measured GFR and published it in 2021. The result is indexed to 1.73 m² body surface area and is classified into KDIGO GFR categories G1–G5.
When to use it
- Staging chronic kidney disease (KDIGO G categories), together with albuminuria (A categories).
- Screening and monitoring kidney function in hypertension, diabetes and cardiovascular disease.
- As a default estimate for drug dosing where the product information accepts eGFR.
When not to use it
- Acute kidney injury or rapidly changing creatinine — the equation assumes steady state.
- Extremes of muscle mass (amputation, cachexia, bodybuilders), pregnancy, or children — use cystatin C or measured GFR, or a paediatric equation.
- When a narrow-therapeutic-range drug label specifies Cockcroft-Gault creatinine clearance.
How it is calculated
eGFR = 142 × min(SCr/κ, 1)^α × max(SCr/κ, 1)^−1.200 × 0.9938^age × 1.012 [if female] κ = 0.7 (female) / 0.9 (male); α = −0.241 (female) / −0.302 (male) SCr in mg/dL (µmol/L ÷ 88.4); result in mL/min/1.73 m²
Clinical pearls and limitations
- Not valid in acute kidney injury, pregnancy, or extremes of muscle mass. For drug dosing, some sources still ask for Cockcroft-Gault.
- SI units: creatinine in µmol/L ÷ 88.4 = mg/dL (e.g. 100 µmol/L ≈ 1.13 mg/dL).
- Many European laboratories still report CKD-EPI 2009 or the EKFC equation; KDIGO 2024 advises using the same equation consistently within a region and avoiding race in eGFR.
- For drug dosing in very small or very large patients, de-index the result: eGFR × BSA / 1.73.
- eGFR 60–89 alone is not CKD: G1 and G2 require another marker of kidney damage (albuminuria, structural or histological changes) for ≥ 3 months.
- Where accuracy matters (e.g. borderline G3a/G3b, sarcopenia), the combined creatinine–cystatin C equation is more accurate.
Frequently asked questions
Why does CKD-EPI 2021 have no race factor?
The 2009 equation multiplied eGFR by 1.159 for Black patients. Because race is a social rather than biological category and the coefficient could delay diagnosis and referral, the NKF-ASN Task Force recommended the refitted 2021 equation without race; KDIGO 2024 advises against using race in eGFR.
CKD-EPI 2021 vs 2009 — how different are the results?
For non-Black patients the 2021 equation gives slightly higher values (a few mL/min/1.73 m² on average), so a small number of patients move up a G category. Compare trends only with the same equation.
eGFR or Cockcroft-Gault for drug dosing?
KDIGO 2024 considers validated eGFR equations appropriate for most dosing decisions. Some product labels, notably the DOACs, were developed with Cockcroft-Gault creatinine clearance, and the EHRA practical guide uses Cockcroft-Gault for DOAC dosing.
How do I enter creatinine in µmol/L?
Divide by 88.4 to get mg/dL — for example 80 µmol/L ÷ 88.4 ≈ 0.90 mg/dL.
Evidence and guidelines
- Primary source: Inker LA et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 2021;385:1737-1749.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024;105(4S):S117-S314 (GFR categories G1–G5; validated equation without race).
- Delgado C et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol 2021;32(12):2994-3015.
Have a follow-up question?
Medelix answers clinical questions from current guidelines and studies — every statement with its source.
Ask Medelix about the eGFR (CKD-EPI 2021)Related calculators
Embed this calculatorFree to use on your website, intranet or teaching page. Copy the code below.
<iframe src="https://medelix.ai/en/embed/ckd-epi-2021" title="eGFR (CKD-EPI 2021) – Medelix" width="100%" height="620" style="border:0;max-width:720px" loading="lazy"></iframe>
<p><a href="https://medelix.ai/en/calculators/egfr-ckd-epi">eGFR (CKD-EPI 2021) calculator by Medelix</a></p>For healthcare professionals and medical students. These tools support, and do not replace, clinical judgement. Always check results against the original source and your local protocols.